Premium
P4‐384: Tau Aggregation Inhibitor (TAI) therapy with rember ™ changes glucose metabolism in the medial temporal lobes in mild and moderate Alzheimer's disease (AD)
Author(s) -
Murray Alison D.,
Staff Roger T.,
Ahearn Trevor S.,
Bentham Peter,
Seng Kwang Meng,
Wischik Claude
Publication year - 2008
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2008.05.2454
Subject(s) - placebo , donepezil , temporal lobe , statistical parametric mapping , medicine , atrophy , dementia , cognitive decline , pathology , nuclear medicine , disease , psychology , cardiology , neuroscience , magnetic resonance imaging , radiology , alternative medicine , epilepsy